The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 7

More JCP Articles

JCP
Depression at 2 Months Postpartum: Results from the French National Perinatal Survey
Original Research

October 8, 2025

The prevalence of postpartum depression (PPD) at 2 months was 16.7%. Factors associated with PPD included age ≤29 or ≥40 years, lower levels of health literacy, and a history…
, , , et al
JCP
Dosing Patients With Oral Iron Supplements: Practical Guidance
Clinical and Practical Psychopharmacology

October 8, 2025

The relevance of iron in neuropsychiatry is discussed, with guidance on how to dose oral iron supplements so as to maximize its absorption.
JCP
Esmethadone (REL-1017) in Patients with Major Depressive Disorder and Antidepressant Tachyphylaxis
Original Research

October 6, 2025

Esmethadone may be a potentially safe and effective adjunctive treatment for patients with MDD and antidepressant tachyphylaxis.
, , , et al
JCP
Symptom Network Analysis of ADHD and Emotional Symptoms in Adults
Original Research

October 1, 2025

Emotional dysregulation symptoms play a significant role in connecting the core ADHD symptoms, particularly those related to the inattention dimension.
, , , et al
JCP
Emory Treatment Resistance Interview for PTSD—Short Version
Original Research

October 1, 2025

The E-TRIP-S offers a simplified method for assessing treatment resistance among PTSD patients.
, ,
JCP
Effects of Interpersonal and Social Rhythm Therapy on Suicidal Ideation in Adults with Bipolar II Depression
Original Research

September 29, 2025

There was no significant difference in suicidal ideation in those receiving IPSRT plus placebo vs IPSRT plus quetiapine. IPSRT has the potential to mitigate suicidal ideation in patients with…
, , , et al
JCP
Why Getting Major Depression Right Matters—For Mothers, Babies, and All of Us
Commentary

September 24, 2025

Commenting on an FDA panel discussion on SSRI use during pregnancy, Dr Payne emphasizes the importance of precision when discussing treatments for mental health conditions.
JCP
Prioritizing Mental Health to Optimize Perinatal, Fetal, and Neonatal Outcomes
Commentary

September 24, 2025

Following an FDA panel discussion on use of SSRIs in pregnancy, the authors highlight the need for balanced conversations and shared decision-making accounting for the risks of untreated disease…
, , , et al
JCP
PSI Response: FDA Panel Discussion Regarding SSRIs in Pregnancy

September 24, 2025

A response from Postpartum Support International expressing concern about the July 2025 FDA panel discussion on SSRIs in pregnancy.
JCP
Ketamine and Esketamine: Is There a Meaningful Clinical Difference?
Commentary

September 22, 2025

The authors comment on a recent chart review by Meisner and colleagues.
,
JCP
Aripiprazole or Bupropion Augmentation vs Switching to Bupropion in Treatment Resistant Depression
Original Research

September 22, 2025

In this model, augmentation with bupropion better balanced efficacy and tolerability in TRD in adults under 85 than did switching to bupropion or augmentation with aripiprazole. Augmentation with aripiprazole…
, , , et al
JCP
The Emerging Science of Clinimetrics
Commentary

September 22, 2025

Dr Guidi highlights recent developments in clinimetric assessment strategies, with particular regard to the features of clinimetric measurements, the domains of clinimetrics, and implications for clinical research and practice.

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe